-
Je něco špatně v tomto záznamu ?
Acute Liver Failure due to Amanita phalloides Poisoning: Therapeutic Approach and Outcome
E. Kieslichova, S. Frankova, M. Protus, D. Merta, E. Uchytilova, J. Fronek, J. Sperl,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu hodnotící studie, časopisecké články
- MeSH
- acetylcystein aplikace a dávkování MeSH
- akutní selhání jater etiologie terapie MeSH
- Amanita MeSH
- antidota aplikace a dávkování MeSH
- antioxidancia aplikace a dávkování MeSH
- dialýza ledvin metody MeSH
- dospělí MeSH
- dřevěné a živočišné uhlí aplikace a dávkování MeSH
- hemoperfuze metody MeSH
- konzervativní terapie metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- otrava houbami komplikace terapie MeSH
- péče o pacienty v kritickém stavu metody MeSH
- plazmaferéza metody MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- seznamy čekatelů mortalita MeSH
- silymarin aplikace a dávkování MeSH
- stupeň závažnosti nemoci * MeSH
- tekutinová terapie metody MeSH
- transplantace jater metody MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
INTRODUCTION: Amanita phalloides poisoning is a potentially fatal cause of acute liver failure. The aim of this study was to analyze the impact of initial patients' characteristics and different treatment modalities on the outcome of patients with liver failure caused by Amanita poisoning. MATERIAL AND METHODS: We retrospectively evaluated 23 patients admitted to our center between July 2007 and August 2016. RESULTS: Mean time interval between Amanita phalloides ingestion and the onset of gastrointestinal symptoms was 12.48 ± 9.88 hours and the interval between ingestion and hospital admission 26.26 ± 15.14 hours. The treatment was intiated by oral decontamination using activated charcoal followed by intravenous rehydration and high doses of intravenous N-acetylcysteine and silibinin. Fourteen patients (61%) underwent extracorporeal elimination method. Ten patients had plasmapheresis, 1 patient had hemoperfusion, and 5 patients had fractionated plasma separation and adsorption. Seven patients who met King's College Criteria were listed for urgent liver transplantation; one of them died before transplantation. Six patients underwent liver transplantation; the mean waiting time was 6.5 ± 12.0 days (range, 1-31 days). One patient died 2 months afterward. All 16 patients who did not meet King's College Criteria and received conservative treatment survived. CONCLUSION: Our results documented a good prognostic value of standard King's College Criteria for indication of urgent liver transplantation in acute liver failure caused by Amanita phalloides poisoning. Fractionated plasma separation and adsorption may contribute to low mortality on the waiting list. Intensive care and extracorporeal elimination methods seem to be crucial points of the conservative treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033342
- 003
- CZ-PrNML
- 005
- 20250402155153.0
- 007
- ta
- 008
- 181008s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.transproceed.2017.11.032 $2 doi
- 035 __
- $a (PubMed)29407307
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kieslichova, E $u Department of Anesthesiology and Intensive Care, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: eva.kieslichova@ikem.cz.
- 245 10
- $a Acute Liver Failure due to Amanita phalloides Poisoning: Therapeutic Approach and Outcome / $c E. Kieslichova, S. Frankova, M. Protus, D. Merta, E. Uchytilova, J. Fronek, J. Sperl,
- 520 9_
- $a INTRODUCTION: Amanita phalloides poisoning is a potentially fatal cause of acute liver failure. The aim of this study was to analyze the impact of initial patients' characteristics and different treatment modalities on the outcome of patients with liver failure caused by Amanita poisoning. MATERIAL AND METHODS: We retrospectively evaluated 23 patients admitted to our center between July 2007 and August 2016. RESULTS: Mean time interval between Amanita phalloides ingestion and the onset of gastrointestinal symptoms was 12.48 ± 9.88 hours and the interval between ingestion and hospital admission 26.26 ± 15.14 hours. The treatment was intiated by oral decontamination using activated charcoal followed by intravenous rehydration and high doses of intravenous N-acetylcysteine and silibinin. Fourteen patients (61%) underwent extracorporeal elimination method. Ten patients had plasmapheresis, 1 patient had hemoperfusion, and 5 patients had fractionated plasma separation and adsorption. Seven patients who met King's College Criteria were listed for urgent liver transplantation; one of them died before transplantation. Six patients underwent liver transplantation; the mean waiting time was 6.5 ± 12.0 days (range, 1-31 days). One patient died 2 months afterward. All 16 patients who did not meet King's College Criteria and received conservative treatment survived. CONCLUSION: Our results documented a good prognostic value of standard King's College Criteria for indication of urgent liver transplantation in acute liver failure caused by Amanita phalloides poisoning. Fractionated plasma separation and adsorption may contribute to low mortality on the waiting list. Intensive care and extracorporeal elimination methods seem to be crucial points of the conservative treatment.
- 650 _2
- $a acetylcystein $x aplikace a dávkování $7 D000111
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a Amanita $7 D000545
- 650 _2
- $a antidota $x aplikace a dávkování $7 D000931
- 650 _2
- $a antioxidancia $x aplikace a dávkování $7 D000975
- 650 _2
- $a dřevěné a živočišné uhlí $x aplikace a dávkování $7 D002606
- 650 _2
- $a konzervativní terapie $x metody $7 D000072700
- 650 _2
- $a péče o pacienty v kritickém stavu $x metody $7 D003422
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a tekutinová terapie $x metody $7 D005440
- 650 _2
- $a hemoperfuze $x metody $7 D006464
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní selhání jater $x etiologie $x terapie $7 D017114
- 650 _2
- $a transplantace jater $x metody $7 D016031
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a otrava houbami $x komplikace $x terapie $7 D009145
- 650 _2
- $a plazmaferéza $x metody $7 D010956
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a dialýza ledvin $x metody $7 D006435
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a silymarin $x aplikace a dávkování $7 D012838
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a seznamy čekatelů $x mortalita $7 D014850
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fraňková, Soňa $u Department of Hepatogastroenterology, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0329475
- 700 1_
- $a Protus, M $u Department of Anesthesiology and Intensive Care, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Merta, D $u Department of Anesthesiology and Intensive Care, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Uchytilova, E $u Department of Anesthesiology and Intensive Care, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Fronek, J $u Department of Transplant Surgery, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Sperl, J $u Department of Hepatogastroenterology, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 773 0_
- $w MED00004556 $t Transplantation proceedings $x 1873-2623 $g Roč. 50, č. 1 (2018), s. 192-197
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29407307 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20250402155149 $b ABA008
- 999 __
- $a ok $b bmc $g 1340883 $s 1030336
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 50 $c 1 $d 192-197 $i 1873-2623 $m Transplantation proceedings $n Transplant Proc $x MED00004556
- LZP __
- $a Pubmed-20181008